| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.27 | 0.06 |